本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Apellis Pharmaceuticals Inc.

20.34
+0.01000.05%
成交量:4.15万
成交额:83.79万
市值:25.74亿
市盈率:56.79
高:20.47
开:20.06
低:20.06
收:20.33
52周最高:35.72
52周最低:16.10
股本:1.27亿
流通股本:7,811.99万
量比:0.58
换手率:0.05%
股息:- -
股息率:- -
每股收益(TTM):0.3581
每股收益(LYR):-1.5970
净资产收益率:14.10%
总资产收益率:5.13%
市净率:6.42
市盈率(LYR):-12.74

数据加载中...

2025/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities